Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study.

Journal of translational medicine - 20 Nov 2019

Lee Kye Hwa, Kim Su-Hwan, Kim Chang Hyen, Min Byung Joo, Kim Grace Juyun, Lim Younggyun, Kim Hun-Sung, Ahn Kang-Min, Kim Ju Han

Abstract excerpt

BACKGROUND: Bisphosphonate-induced osteonecrosis of the jaw (BRONJ) presents with a typical pattern of jaw necrosis in patients who have been prescribed bisphosphonates (BPs) and other antiangiogenetic drugs to treat osteoporosis or bone-related complications of cancer. METHODS: This study divided 38 patients with BRONJ into two groups according to the prescribing causes: cancer (n = 13) and osteoporosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Bone health and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Gene Frequency

Share to Genetic Association Studies

Share to Genetic Variation

Share to Neoplasms

Share to Osteoporosis

Source

Open in PubMed Open full text

Identifiers

PMID: 31747953
DOI: 10.1186/s12967-019-2129-3
PMCID: PMC6868688

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study.PMID 31747953Read ↗

Genome-wide Association Study Identified Chromosome 8 Locus Associated with Medication-Related Osteonecrosis of the Jaw.Semantic proximity Read ↗

Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3.Semantic proximity Read ↗

Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives.Semantic proximity Read ↗

SIRT1/HERC4 Locus Associated With Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association Analysis.Semantic proximity Read ↗

Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series.Semantic proximity Read ↗

Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fracturesSemantic proximity Read ↗

From bone alterations to tumours: Genetic drivers linking Paget's disease of bone to cancer.Semantic proximity Read ↗

Metaanalysis Reveals Genetic Correlates of Osteoporosis PathogenesisSemantic proximity Read ↗

Identification of rare genetic variants in familial forms and unrelated cases of bisphosphonates-associated atypical femur fracture.Semantic proximity Read ↗

Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw.Semantic proximity Read ↗

Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures.Semantic proximity Read ↗

Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.